NASDAQ:GALT
$1.33
(
10.42%
)
Friday, 3rd Feb 2023
Galectin Therapeutics Inc. Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $1.07 | $1.33 | Friday, 3rd Feb 2023 GALT stock ended at $1.33. This is 10.42% more than the trading day before Thursday, 2nd Feb 2023. During the day the stock fluctuated 9.02% from a day low at $1.22 to a day high of $1.33. |
| 90 days | $1.02 | $1.38 | |
| 52 weeks | $1.02 | $2.57 |
Historical Galectin Therapeutics Inc. prices
| Date | Open | High | Low | Close | Volume |
| 2023-02-03 | $1.24 | $1.33 | $1.22 | $1.33 | 211 418 |
| 2023-02-02 | $1.21 | $1.21 | $1.18 | $1.20 | 68 169 |
| 2023-02-01 | $1.18 | $1.18 | $1.15 | $1.15 | 56 794 |
| 2023-01-31 | $1.13 | $1.18 | $1.12 | $1.16 | 65 361 |
| 2023-01-30 | $1.11 | $1.16 | $1.11 | $1.13 | 101 461 |
| 2023-01-27 | $1.11 | $1.13 | $1.08 | $1.11 | 94 522 |
| 2023-01-26 | $1.14 | $1.14 | $1.09 | $1.11 | 38 743 |
| 2023-01-25 | $1.10 | $1.12 | $1.10 | $1.10 | 38 814 |
| 2023-01-24 | $1.12 | $1.12 | $1.09 | $1.11 | 45 779 |
| 2023-01-23 | $1.13 | $1.14 | $1.10 | $1.10 | 43 381 |
| 2023-01-20 | $1.15 | $1.16 | $1.11 | $1.13 | 80 941 |
| 2023-01-19 | $1.15 | $1.17 | $1.14 | $1.14 | 13 706 |
| 2023-01-18 | $1.15 | $1.18 | $1.15 | $1.15 | 49 136 |
| 2023-01-17 | $1.15 | $1.18 | $1.14 | $1.17 | 88 146 |
| 2023-01-13 | $1.16 | $1.17 | $1.14 | $1.14 | 45 503 |
| 2023-01-12 | $1.14 | $1.17 | $1.11 | $1.14 | 57 342 |
| 2023-01-11 | $1.14 | $1.18 | $1.14 | $1.15 | 58 100 |
| 2023-01-10 | $1.15 | $1.18 | $1.13 | $1.18 | 68 500 |
| 2023-01-09 | $1.20 | $1.20 | $1.12 | $1.17 | 77 300 |
| 2023-01-06 | $1.16 | $1.18 | $1.11 | $1.14 | 32 546 |
| 2023-01-05 | $1.21 | $1.21 | $1.07 | $1.13 | 123 927 |
| 2023-01-04 | $1.21 | $1.22 | $1.15 | $1.19 | 86 817 |
| 2023-01-03 | $1.16 | $1.22 | $1.12 | $1.18 | 60 776 |
| 2022-12-30 | $1.08 | $1.17 | $1.07 | $1.13 | 137 443 |
| 2022-12-29 | $1.04 | $1.20 | $1.04 | $1.15 | 195 923 |
| 2022-12-28 | $1.11 | $1.14 | $1.02 | $1.03 | 214 107 |
| 2022-12-27 | $1.18 | $1.20 | $1.10 | $1.13 | 118 210 |
| 2022-12-23 | $1.23 | $1.31 | $1.14 | $1.22 | 127 234 |
| 2022-12-22 | $1.23 | $1.31 | $1.18 | $1.18 | 137 682 |
| 2022-12-21 | $1.22 | $1.33 | $1.10 | $1.23 | 306 655 |
| 2022-12-20 | $1.14 | $1.24 | $1.14 | $1.19 | 99 430 |
| 2022-12-19 | $1.15 | $1.28 | $1.15 | $1.17 | 202 652 |
| 2022-12-16 | $1.14 | $1.18 | $1.12 | $1.17 | 65 635 |
| 2022-12-15 | $1.10 | $1.16 | $1.10 | $1.16 | 68 289 |
| 2022-12-14 | $1.14 | $1.18 | $1.10 | $1.12 | 67 197 |
| 2022-12-13 | $1.14 | $1.18 | $1.11 | $1.12 | 66 611 |
| 2022-12-12 | $1.16 | $1.18 | $1.07 | $1.15 | 206 875 |
| 2022-12-09 | $1.15 | $1.20 | $1.15 | $1.16 | 42 555 |
| 2022-12-08 | $1.20 | $1.21 | $1.15 | $1.17 | 58 508 |
| 2022-12-07 | $1.23 | $1.23 | $1.18 | $1.19 | 63 362 |
| 2022-12-06 | $1.15 | $1.22 | $1.15 | $1.19 | 37 498 |
| 2022-12-05 | $1.19 | $1.20 | $1.13 | $1.15 | 120 086 |
| 2022-12-02 | $1.28 | $1.28 | $1.19 | $1.22 | 55 583 |
| 2022-12-01 | $1.30 | $1.30 | $1.24 | $1.24 | 48 031 |
| 2022-11-30 | $1.22 | $1.28 | $1.20 | $1.27 | 41 535 |
| 2022-11-29 | $1.33 | $1.33 | $1.23 | $1.25 | 43 274 |
| 2022-11-28 | $1.31 | $1.33 | $1.26 | $1.29 | 16 771 |
| 2022-11-25 | $1.36 | $1.37 | $1.26 | $1.29 | 74 098 |
| 2022-11-23 | $1.20 | $1.38 | $1.20 | $1.35 | 62 115 |
| 2022-11-22 | $1.21 | $1.30 | $1.21 | $1.24 | 42 594 |
About Galectin Therapeutics Inc.
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatiti... GALT Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
